HomeNewsBusinessInnerwear maker VIP forays into making COVID-19 masks
Trending Topics

Innerwear maker VIP forays into making COVID-19 masks

The company plans to make 3 lakh to 5 lakh masks every month, with a focus on expanding its reach into tier 1 and tier 2 cities across India.

September 11, 2020 / 20:15 IST
Story continues below Advertisement

VIP Clothing Ltd, known for its range of innerwear, has added reusable 4-ply cotton masks and N95 masks to its existing range of affordable masks for adults and children. With this, the company has forayed into the medical distribution chain.

Story continues below Advertisement

Under the latest introduction, the innerwear maker plans to make 3 lakh to 5 lakh masks every month, with a focus on expanding its reach into tier 1 and tier 2 cities across India. For this, VIP Clothing's mask range will go live on the brand's e-commerce page and will soon be made available at regular retail stores as well as on online platforms like Amazon and Flipkart.

The company had ventured into the manufacture of affordable masks for adults and children about a month ago.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show